Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02171 (Long intergenic non-protein coding RNA 2171) is a member of the long intergenic non-coding RNA (lincRNA) family, a class of RNAs greater than 200 nucleotides in length that do not encode proteins and are located between protein-coding genes in the genome[1][3]. LincRNAs are known to function in various aspects of gene regulation, both at the transcriptional and post-transcriptional level, and can act in *cis* (locally) or *trans* (distally). They are involved in processes such as chromatin remodeling, transcriptional regulation, and miRNA sponge activity, with roles in cell proliferation, differentiation, and disease including cancer[1][3]. However, for LINC02171 specifically, there is currently no direct experimental evidence characterizing its molecular or biological functions, disease roles, or therapeutic relevance in the scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2171 (LINC02171).